Debate: FERTILITY TREATMENT ADD-ONS: DO THEY ADD UP?

10 March 2017

Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent’s Park, London NW1 4RG

29 March 2017 6pm (wine reception), 6.30pm-8.30pm (panel discussion)

This Progress Educational Trust event, which is sponsored by the British Fertility Society, will begin with a wine reception at 6pm followed by a panel discussion at 6.30pm. To reserve your free place, email sstarr [at] progress.org.uk

The panel discussion will be chaired by FIONA FOX (Chair of Trustees at the Progress Educational Trust and Chief Executive of the Science Media Centre) with speakers PROFESSOR ADAM BALEN (Chair of the British Fertility Society), SALLY CHESHIRE (Chair of the Human Fertilisation and Embryology Authority), DR SIMON FISHEL (Founder and President of CARE Fertility) and DR RAJ MATHUR (Lead for Reproductive Medicine at St Mary’s Hospital in Manchester).

Fertility treatment ‘add-ons’ are procedures and treatments offered alongside IVF – sometimes at considerable expense to the patient – which may not be supported by robust evidence. The benefits, harms and appropriateness of add-ons are often open to question, and the role of add-ons in fertility treatment has become a matter of heated debate among professionals and a source of confusion for patients.

Recently, add-ons have been discussed and debated in a controversial episode of the BBC1 programme Panorama entitled Inside Britain’s Fertility Business, in two studies published by in the British Medical Journal, in a study published by the journal Human Reproduction, and in work undertaken by the UK’s fertility regulator – the Human Fertilisation and Embryology Authority (HFEA).

Our event will ask:

• What counts as an add-on?

• Who is best placed to judge the evidence for add-ons, and what is the ideal standard of evidence?

• How much evidence is it reasonable to expect, before a treatment is offered to patients?

• What is the role of the HFEA, the National Institute for Health and Care Excellence and professional bodies such as the British Fertility Society, in helping patients navigate add-ons?

• What is the duty of the medical professional, and what is the role of patient choice?

Much of the event’s running time will be devoted to letting YOU put questions and comments to the speakers.

Advertisements

Radio: Controlling people

17 October 2011

BBC World Service, available indefinitely as a podcast or listen online via the iPlayer

From the programme’s website: “The world’s population is due to reach seven billion people this year, and by around 2050 it could grow by yet another two billion.

Using India as an exemplar, Professor Matthew Connelly of Columbia University, New York, documents a global campaign that began with the best humanitarian ideals, but which led to authoritarian control over some of the world’s poorest citizens.

He uncovers a story of tragic mistakes and sometimes terrible human rights abuses, and shows how we will be living with the consequences for decades to come.”


Consultation: Emerging biotechnologies

31 March 2011

The Nuffield Council on Bioethics will be soon launching a call for views and evidence on the ethical issues raised by emerging biotechnologies. By looking at both current examples, such as synthetic biology and nanotechnology, and taking lessons from older cases, such as GM crops and IVF, the Council is interested in the way society and policy makers respond to new biotechnologies and how benefits from these technologies can be secured in an ethically appropriate manner.

Find out more about the Working Party and sign up for alerts about this consultation here.